The gold standard for diagnosing MDS is typically based on a combination of factors including bone marrow morphology, progenitor cell count, and cytogenetics. However, the integration of
Flow cytometry, particularly the use of integrated flow cytometric score (iFS), has emerged as a valuable tool to enhance diagnostic accuracy and prognostic assessment in MDS.
7 answers
Caterina
Wed Nov 20 2024
This technique involves obtaining a sample of bone marrow aspirate and preparing it as a smear.
BonsaiStrength
Wed Nov 20 2024
Pathologists then examine the smear under a microscope to assess the morphology of the cells.
Martino
Wed Nov 20 2024
Evaluating bone marrow morphology plays a crucial role in diagnosing myelodysplastic syndromes (MDS).
Sofia
Wed Nov 20 2024
The aspirate smear provides detailed information about the cellular architecture and distribution within the bone marrow.
Alessandro
Wed Nov 20 2024
It allows for the identification of abnormalities such as dysplastic changes, ring sideroblasts, and increased blasts.